Federal and Regulatory Outreach
AMRPA Response to CMS MA RFI on Health Equity & Access Issues in the Medicare Advantage Program
September 1, 2022
Medicare Advantage Prior Authorization Regulatory
AMRPA Response to the FY 2023 Inpatient Rehabilitation Facility Prospective Payment System Proposed Rule
May 31, 2022
IRF PPS IRF QRP
AMRPA Statement on OIG Prior Authorization Report
April 29, 2022
Prior Authorization
AMRPA Comments on IRF PAI version 4.0
March 9, 2022
IRF-PAI Regulatory
Report: Medicare Advantage Prior Authorization
March 8, 2022
Medicare Advantage Prior Authorization
Response to CMS Request for Information on Prior Authorization
March 8, 2022
Medicare Advantage Prior Authorization Regulatory
Response to Advance Notice for Medicare Advantage Plan Year 2023
March 8, 2022
Medicare Advantage Prior Authorization Regulatory
AMRPA’s Comments to the National Quality Forum on an IRF QRP Measure Under Consideration
January 26, 2022
IRF QRP
AMRPA Comments on Medicare Payment Advisory Commission (MedPAC)’s FY 2023 IRF Payment Update Recommendation
January 11, 2022
MedPAC
AMRPA Joint Letter to HHS Sec. Becerra on LTACHs and IRFs
January 5, 2022
COVID-19 Medicare Advantage Prior Authorization Regulatory
AMRPA Statement on Senate Reintroduction of Improving Seniors’ Timely Access to Care Act
October 21, 2021
Legislative Medicare Advantage Prior Authorization
AMRPA Comments on CY 2023 Medicare Physician Fee Schedule